DOCSLIB.ORG

Cytotoxic and Biochemical Effects of Thymidine and 3-Deazauridine on Human Tumor Cells1

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Cytotoxic and Biochemical Effects of Thymidine and 3-Deazauridine on Human Tumor Cells1 [CANCER RESEARCH 44, 2534-2539. June 1984] Cytotoxic and Biochemical Effects of Thymidine and 3-Deazauridine on Human Tumor Cells1 Arnold Lockshin, John T. Mendoza, Beppino C. Giovanella,2 and John S. Stehlin, Jr. St. Joseph Hospital Laboratory for Cancer Research, Houston, Texas 77002 ABSTRACT cells, thymidine-resistant human malignant B-cells have much lower ratios of these activities (6, 19). The cause of thymidine- Cytotoxicity and perturbations of the deoxyribonucleoside tri- induced inhibition of DNA synthesis in mammalian cells has been phosphate pools caused by thymidine were studied in thymidine- ascribed to depletion of the intracellular dCTP pool brought about sensitive and -resistant human tumor cells. Incubation with 1 mw by allosteric effects of dTTP on ribonucleotide reducíase(2, 33, thymidine reduced cell viability by more than 90% in the three 36). Other investigators have concluded that the decrease in the sensitive cell lines (two melanomas and one adrenal carcinoma) dCTP pool is too small to account for growth inhibition of L1210 and reduced the growth rate without decreasing the viability of murine leukemia cells (14) and that high levels of dTTP (and/or resistant LO melanoma cells. Thymidine (1 HIM)greatly increased other dNTPs3) interact with a regulatory protein for DNA polym- the ratio of the deoxythymidine 5'-triphosphate to deoxycytidine 5'-triphosphate pools in the sensitive cells compared to LO cells erase (37). Yet another interpretation is that imbalance of the pyrimidine dNTP pools brought about by supranormal levels of and also caused larger relative increases in the pool sizes of deoxyguanosine 5'-triphosphate and deoxyadenosine 5'-tri- exogenous thymidine causes misincorporation of bases into DNA, which leads to mutagenicity and cytotoxicity (4). phosphate in the sensitive compared to the resistant cells. 3-Deazauridine inhibits the growth of microbial and murine 3-Deazauridine, known to inhibit synthesis of deoxycytidine 5'-triphosphate and cytidine 5'-triphosphate in other cell lines, tumor cells in culture and of transplantable mouse tumors in vivo (5, 39). In patients with acute leukemia, infusions of 3-deazauri potentiated the cytotoxicity of thymidine for thymidine-sensitive dine resulted in hematological improvement but no significant BE melanoma and LO cells. In LO cells, 3-deazauridine (50 UM) responses (41). 3-Deazauridine 5'-triphosphate, an intracellular decreased the intracellular pool of deoxycytidine 5'-triphosphate metabolite of 3-deazauridine, inhibits CTP synthetase from mu to the level obtained with 1 rnw thymidine. Lower concentrations rine tumor cells and from calf liver, thereby lowering intracellular of deoxycytidine as compared to cytidine were required to pro levels of CTP and indirectly those of dCTP (5, 26, 27). A second tect BE and LO cells against the cytotoxicity of thymidine plus ary effect of 3-deazauridine in these cells is inhibition by 3- 3-deazauridine. Deoxycytidine also was more effective than was deazauridine 5'-diphosphate of the reduction of CDP to dCDP cytidine in preventing loss of cell viability after exposure to mediated by ribonucleoside reducíase (5). Cytidine and less thymidine or to 3-deazauridine individually. In these human mel effectively deoxycytidine or uridine counteract growth inhibition anoma cells, ribonucleotide reducíase may be a major site of caused by 3-deazauridine in murine adenocarcinoma Ca755 and action of thymidine, of 3-deazauridine, and of both drugs in in L1210 cells, whereas Ihymidine or deoxyuridine do not have combination. this effect (5,26). 3-Deazauridine is not incorporated into nucleic These results indicate that in human tumor cells the cytotoxic acids (39). effect of thymidine correlates with greater perturbations of the The major known effects of thymidine and 3-deazauridine pyrimidine deoxyribonucleoside 5'-triphosphate pools and that metabolites on pyrimidine nucleotide biosynthesis are presenled thymidine and 3-deazauridine, which independently reduce the intracellular levels of deoxycytidine 5'-triphosphate, act synergis- in Chart 1. Other biochemical effecls include feedback inhibilion by dTTP of Ihymidine kinase (15) and dCMP deaminase (25) and tically against human tumor cells. inhibilion by 3-deazauridine and ils 5'-monophosphate nucleo- lide of cylidine deaminase and dCMP deaminase, respectively INTRODUCTION (10). We are exploring the potenlial Iherapeulic value of combining High concentrations of thymidine selectively kill certain human fhymidine wilh agenls lhal deplete the dCTP pool. Using human tumor cells In vitro (21), and continual infusions of thymidine tumor cell lines, we are interesled in determining (a) if differences cause regression of human tumor heterotransplants in nude in Ihe inlracellular dNTP pools are consislenl wilh sensilivily and (athymic) mice (22). Clinical evidence of antitumor effect has resislance to thymidine, and (b) if drugs which deplete dCTP been observed with T-cell leukemias, lymphomas, and metastatic pools enhance Ihe cyloloxicily of Ihymidine. We report here our melanomas when plasma levels of about 1 mw thymidine have studies wilh 4 human cell lines, 3 derived from melanomas and been maintained (3, 7, 19, 20). Thymidine must be converted to one from an adrenal carcinoma. A preliminary report of some of dTTP in order to cause cytotoxicity or cytostasis. The sensitivity Ihese findings has been published (24). of human malignant T-cells to thymidine has been attributed to the high levels of thymidine-phosphorylating activity relative to dephosphorylating activity in these cells. Compared to these T- MATERIALS AND METHODS 1 Supported by The Stehlin Foundation for Cancer Research and by the Sid Cells. The human melanoma cell lines CA, BE, and LO were obtained from this laboratory (13), and the SW-13 human adrenal tumor cells were Richardson Foundation, Dallas, TX. 2 To whom requests for reprints should be addressed. Received November 14, 1983; accepted March 14, 1984. 3The abbreviation used is: dNTP, deoxyribonucleoside 5'-triphosphate. 2534 CANCER RESEARCH VOL. 44 Downloaded from cancerres.aacrjournals.org on September 24, 2021. © 1984 American Association for Cancer Research. Thymidine and 3-Deazauridine 3 Deazaundine Thymidine polycytidylate copolymer was used for the dCTP assays. The polymeri zation reactions were conducted in 96-well culture plates, and aliquots (90 ííl)ofeach reaction mixture were spotted on discs of Whatman GFA RNA ||X 1/\dCTPA1ÕtDeoxycytidineglass fiber filters (pretreated with cold 5% trichloroacetic acid containing \*¿f 1% inorganic sodium pyrophosphate) placed on a manifold. After 10 min, ^v DAUOP each dish was washed 12 times with the cold trichloroacetic acid- /CTP \ICTP SynthetaseX T inorganic sodium pyrophosphate solution followed by 4 washes with MiT. 'JTP «}tCytidineI| 100% methanol and 3 with diethyl ether. For each cell line, dNTP DAUTP \\ determinations were performed on extracts from 3 separate experiments tRibonucleolíde with at least 2 flasks/treatment. Reducíasettt/dTTP/DNA RESULTS Effect of Thymidine on Growth Rate and Cell Viability. At plating densities of 500,000 cells/75 sq cm flask, the logarithmic Chart 1. Major effects of thymidine and 3-deazauridine metabolites on pyrimi- phase growth rates of all 4 cell lines were approximately the dme nudeotide biosynthesis, x, enzyme inhibition. See text for details. DAUDP, 3- same (doubling times ranging from 29 to 33 hr). Under these deazauridine 5'-diphosphate; DAUTP, 3-deazauridine 5'-tríphosphate. conditions, 48-hr incubation of CA, BE, or SW-13 cells with 1 HIMthymidine prevented cell division and decreased cell viability from Dr. A. Leibovitz (23). Cells were maintained as monolayer cultures in Eagle's minima! essential medium containing penicillin (50 units/ml), by more than 90%. LO cells divided more slowly in the presence of thymidine (see below), but their viability was enhanced after streptomycin (50 ng/ml), and supplemental 2 mw glutamine, all from 24-hr incubation and was not impaired for up to 72 hr (Table 1). Grand Island Biological Co. (Grand Island, NY), and 10% heat-inactivated fetal calf serum from Reheis Chemical Co. (Phoenix, AZ). Cultures were Effect of Thymidine on Intracellular dNTP Levels. Chart 2 incubated at 37°in a humidified 5% CO2 atmosphere. Periodic tests for shows the changes in the dNTP pools caused by incubating Mycoplasma contamination were negative. these cell lines with 1 mwi thymidine. After 24 hr, the dTTP pools Chemicals. [mef/7y/-3H]dTTP (60 Ci/mmol), [5-3H]dCTP (30 Ci/mmol), of the sensitive lines increased 60-fold or more, whereas the [8-3H]dGTP, (18 Ci/mmol), and [8-3H]dATP (17 Ci/mmol) were purchased relative increase in the LO cells was less than half these values. •%. from ICN Clinical Radioisotopes Div. (Irvine, CA). Lyophilized noncovalent double-stranded copolymers of deoxypolyadenylate-deoxypolythymidy- Table 1 late, deoxypolyinosinate-deoxypolycytidylate. and deoxypolyguanylate- Effect of 1 mu thymidine on viability of human tumor cells deoxypolycytidylate were obtained from P-L Biochemicals, Inc. (Milwau Cells (500.000) were plated in 75-sq cm culture flasks. After 24 hr, fresh medium kee, Wl), and Micrococcus /úfeosDNA polymerase (EC 2.7.7.7) (specific with or without 1 mu thymidine was added. The cells were harvested at the times indicated and were replated for colony formation. activity, 469 units/mg protein) was purchased from Miles Laboratories control8)CA0.38 viability (fraction of (Elkhart, IN). Thymidine, 3-deazauridine, and other nonlabeled chemicals Thymidine treatment were from Sigma Chemical Co. (St. Louis, MO). (hr)24 Growth and Cytotoxicity Assays. Cells were seeded in 75-sq cm ±0.06" ±0.03 ±0.07 ±0.06 culture flasks and allowed to plate for 24 hr, at which time the medium 48 0.08 ±0.04 0.05 ±0.01SW-130.740.08 ±0.02LO1.361.05 ±0.10 was removed and replaced with fresh medium with or without drugs. At 72Cell 0.006 ±0.003BE0.24 0.95 ±0.04 indicated times, cells from one-half of the flasks were harvested with 8 Incubation without thymidine.
Load more

Recommended publications
  • Nucleotide Metabolism Pathway: the Achilles' Heel for Bacterial Pathogens
    REVIEW ARTICLES Nucleotide metabolism pathway: the achilles’ heel for bacterial pathogens Sujata Kumari1,2,* and Prajna Tripathi1,3 1National Institute of Immunology, New Delhi 110 067, India 2Present address: Department of Zoology, Magadh Mahila College, Patna University, Patna 800 001, India 3Present address: Institute of Molecular Medicine, Jamia Hamdard, New Delhi 110 062, India de novo pathway, the nucleotides are synthesized from Pathogens exploit their host to extract nutrients for their survival. They occupy a diverse range of host simple precursor molecules. In the salvage pathway, the niches during infection which offer variable nutrients preformed nucleobases or nucleosides which are present accessibility. To cause a successful infection a patho- in the cell or transported from external environmental gen must be able to acquire these nutrients from the milieu to the cell are utilized to form nucleotides. host as well as be able to synthesize the nutrients on its own, if required. Nucleotides are the essential me- tabolite for a pathogen and also affect the pathophysi- Purine biosynthesis pathway ology of infection. This article focuses on the role of nucleotide metabolism of pathogens during infection The purine biosynthesis pathway is universally conserved in a host. Nucleotide metabolism and disease pathoge- in living organisms (Figure 1). As an example, we here nesis are closely related in various pathogens. Nucleo- present the pathway derived from well-studied Gram- tides, purines and pyrimidines, are biosynthesized by positive bacteria Lactococcus lactis. In the de novo the de novo and salvage pathways. Whether the patho- pathway the purine nucleotides are synthesized from sim- gen will employ the de novo or salvage pathway dur- ple molecules such as phosphoribosyl pyrophosphate ing infection is dependent on various factors, like (PRPP), amino acids, CO2 and NH3 by a series of enzy- availability of nucleotides, energy condition and pres- matic reactions.
    [Show full text]
  • Guanosine-Based Nucleotides, the Sons of a Lesser God in the Purinergic Signal Scenario of Excitable Tissues
    International Journal of Molecular Sciences Review Guanosine-Based Nucleotides, the Sons of a Lesser God in the Purinergic Signal Scenario of Excitable Tissues 1,2, 2,3, 1,2 1,2, Rosa Mancinelli y, Giorgio Fanò-Illic y, Tiziana Pietrangelo and Stefania Fulle * 1 Department of Neuroscience Imaging and Clinical Sciences, University “G. d’Annunzio” of Chieti-Pescara, 66100 Chieti, Italy; [email protected] (R.M.); [email protected] (T.P.) 2 Interuniversity Institute of Miology (IIM), 66100 Chieti, Italy; [email protected] 3 Libera Università di Alcatraz, Santa Cristina di Gubbio, 06024 Gubbio, Italy * Correspondence: [email protected] Both authors contributed equally to this work. y Received: 30 January 2020; Accepted: 25 February 2020; Published: 26 February 2020 Abstract: Purines are nitrogen compounds consisting mainly of a nitrogen base of adenine (ABP) or guanine (GBP) and their derivatives: nucleosides (nitrogen bases plus ribose) and nucleotides (nitrogen bases plus ribose and phosphate). These compounds are very common in nature, especially in a phosphorylated form. There is increasing evidence that purines are involved in the development of different organs such as the heart, skeletal muscle and brain. When brain development is complete, some purinergic mechanisms may be silenced, but may be reactivated in the adult brain/muscle, suggesting a role for purines in regeneration and self-repair. Thus, it is possible that guanosine-50-triphosphate (GTP) also acts as regulator during the adult phase. However, regarding GBP, no specific receptor has been cloned for GTP or its metabolites, although specific binding sites with distinct GTP affinity characteristics have been found in both muscle and neural cell lines.
    [Show full text]
  • T E C H N Ic a L R E F E R E N
    Abbreviations A E α alpha ED50 effective dose (for 50% of effect) Ab antibody EDTA ethylenediaminetetraacetic acid Ac-DEVD-AMC acetyl-Asp-Glu-Val-Asp-7-amino-4-methyl coumarin EGF epidermal growth factor (fluorogenic substrate for caspase-3/7) EGFR epidermal growth factor receptor Ac-DEVD-CHO acetyl-Asp-Glu-Val-Asp-1-aldehyde EGTA ethylene glycol-bis(2-aminoethylether)-N,N,N′,N′-tetraacetic acid (reversible aldehyde inhibitor of caspase-3/7) ELISA enzyme-linked immunosorbent assay Ac-DEVD-pNA acetyl-Asp-Glu-Val-Asp-pNA (colorimetric substrate for caspase-3/7) em emission Ac-YVAD-AMC acetyl-Tyr-Val-Ala-Asp-amino methyl coumarin ERK1, 2 extracellular signal-regulated protein kinase 1, 2 (fluorogenic substrate for caspase-1) EtBr ethidium bromide Ac-YVAD-CHO acetyl-Tyr-Val-Ala-Asp-1-aldehyde EtOH ethanol (reversible aldehyde inhibitor of caspase-1) ex excitation ADP adenosine diphosphate Ad-2 adenovirus-2 F AKAP A-kinase anchoring protein FAB/MS fast atomic bombardment mass spectrometry a.m.u. atomic mass unit FACS fluorescence-activated cell sorting AMC 7-amino-4-methyl coumarin FGF fibroblast growth factor amol attomole (10–18 mole) FITC fluorescein isothiocyanate AMP adenosine monophosphate FITC-VAD-FMK FITC-carbobenzoxy-valyl-alanyl-aspartyl-[O-methyl]- AMV avian myeloblastosis virus fluoromethylketone (fluorescent marker for caspase activity) AP alkaline phosphatase FL fluorescein –15 AP1, 2 activator protein 1, 2 fmol femtomole (10 mole) APC film automatic processor-compatible film G ARE AU-rich element γ gamma ATP adenosine triphosphate
    [Show full text]
  • Arthur Kornberg
    A RTHUR K O R N B E R G The biologic synthesis of deoxyribonucleic acid Nobel Lecture, December 11, 1959 The knowledge drawn in recent years from studies of bacterial transforma- tion 1 and viral infection of bacterial cells 2,3 combined with other evidences, has just about convinced most of us that deoxyribonucleic acid (DNA) is the genetic substance. We shall assume then that it is DNA which not only directs the synthesis of the proteins and the development of the cell but that it must also be the substance which is copied so as to provide for a similar development of the progeny of that cell for many generations. DNA, like a tape recording, carries a message in which there are specific instructions for a job to be done. Also like a tape recording, exact copies can be made from it so that this information can be used again and elsewhere in time and space. Are these two functions, the expression of the code (protein synthesis) and the copying of the code (preservation of the race) closely integrated or are they separable? What we have learned from our studies over the past five years and what I shall present is that the replication of DNA can be exam- ined and at least partially understood at the enzymatic level even though the secret of how DNA directs protein synthesis is still locked in the cell. First I should like to review very briefly some aspects of DNA structure which are essential for this discussion. Analysis of the composition of samples of DNA from a great variety of sources and by many investigators4 revealed the remarkable fact that the purine content always equals the pyrimidine content.
    [Show full text]
  • (12) United States Patent (10) Patent No.: US 7,794,936 B1 Benner Et Al
    US007794936B1 (12) United States Patent (10) Patent No.: US 7,794,936 B1 Benner et al. (45) Date of Patent: Sep. 14, 2010 (54) USING THYMIDINE ANALOGS TO IMPROVE Michiko Kimoto, Rie Kawai, Tsuneo Mitsui, Shigeyuki Yokoyama, REPLICATION IN AN EXPANDED GENETIC Ichiro Hirao An unnatural base pair system for efficient PCR ampli ALPHABET fication and functionalization of DNA molecules Nucleic Acids Research, 2009, vol. 37, No. 2 e14. (76) Inventors: Steven Albert Benner, 1501 NW. 68" Chen, F., Gaucher, E. A., Leal, N. A., Hutter, D., Havemann, S.A., Govindarajan, S., Ortlund, E. A., Benner, S.A. (2010) Reconstructed Ter, Gainesville, FL (US) 32605-4147: evolutionary adaptive paths give polymerases accepting reversible Albert Michael Sismour, 85 Hancock terminators for sequencing and SNP detection. Proc. Natl. Acad. Sci. St., Apt. 7, Cambridge, MA (US) 02139 USA 107, 5, 1948-1953. (*) Notice: Subject to any disclaimer, the term of this * cited by examiner patent is extended or adjusted under 35 U.S.C. 154(b) by 534 days. Primary Examiner Heather Calamita (21) Appl. No.: 11/541.295 (57) ABSTRACT (22) Filed: Sep. 29, 2006 This invention relates to nucleoside, nucleotide, and oligo (51) Int. Cl. nucleotide analogs that incorporate non-standard nucleobase CI2O I/68 (2006.01) analogs, those that present a pattern of hydrogen bonds to a paired nucleobase analog in a complementary strand that is (52) U.S. Cl. ........................ 435/6:536/22.1536/24.33 different from the pattern presented by adenine, guanine, (58) Field of Classification Search ....................... None cytosine, and thymine. Most specifically, this invention dis See application file for complete search history.
    [Show full text]
  • A New Base Pair with an Alternative Hydrogen Bonding Pattern Zunyi Yang, Daniel Hutter, Pinpin Sheng, A
    Published online 29 October 2006 Nucleic Acids Research, 2006, Vol. 34, No. 21 6095–6101 doi:10.1093/nar/gkl633 Artificially expanded genetic information system: a new base pair with an alternative hydrogen bonding pattern Zunyi Yang, Daniel Hutter, Pinpin Sheng, A. Michael Sismour and Steven A. Benner* Foundation for Applied Molecular Evolution, 1115 NW 4th Street, Gainesville, FL 32601, USA Received June 14, 2006; Revised August 9, 2006; Accepted August 12, 2006 ABSTRACT have sought to change hydrogen-bonding patterns and to control the outcome with sulfur and/or steric interactions. To support efforts to develop a ‘synthetic biology’ Kool and his group have sought to dispense with hydrogen based on an artificially expanded genetic informa- bonding entirely (9,10), as have Romesberg, Schultz and tion system (AEGIS), we have developed a route their coworkers (11,12) using hydrophobic interactions. to two components of a non-standard nucleobase In the opposite direction, Minakawa et al. have sought to pair, the pyrimidine analog 6-amino-5-nitro-3- increase the number of interpair hydrogen bonds (13). (10-b-D-20-deoxyribofuranosyl)-2(1H)-pyridone (dZ) Despite the success of this work, alternative nucleic acid- and its Watson–Crick complement, the purine like systems that deviate less drastically from the standard analog 2-amino-8-(10-b-D-20-deoxyribofuranosyl)- design have had, to date, the technological success and sup- imidazo[1,2-a]-1,3,5-triazin-4(8H)-one (dP). These ported best the emerging field of synthetic biology (14). If implement the pyDDA:puAAD hydrogen bonding nitrogen and oxygen are used as the only heteroatoms, six different hydrogen-bonding patterns can be directly placed pattern (where ‘py’ indicates a pyrimidine analog within the standard Watson–Crick geometry.
    [Show full text]
  • (12) United States Patent (10) Patent No.: US 6,673,576 B1 Usuda Et Al
    USOO6673576B1 (12) United States Patent (10) Patent No.: US 6,673,576 B1 USuda et al. (45) Date of Patent: Jan. 6, 2004 (54) PROCESS FOR PRODUCING NUCLEIC OTHER PUBLICATIONS ACDS K. W. Harlow, et al., Journal of Bacteriology, vol. 177, No. (75) Inventors: Yoshihiro Usuda, Kawasaki (JP); 8, pp. 2236 to 2240, “Cloning and Characterization of the Hisashi Kawasaki, Kawasaki (JP); gsk Gene Encoding Guanosine Kinase of Escherichia coli, Megumi Shimaoka, Kawasaki (JP); Apr. 1995. Takashi Utagawa, Kawasaki (JP) H. Mori, et al., Journal of Bacteriology, vol. 177, No. 17, pp. 4921 to 4926, “Cloning of a Guanosine-Inosine Kinase (73) Assignee: Ajinomoto Co., Inc., Tokyo (JP) Gene of Escherichia coli and Characterization of the Puri fied Gene Product”, Sep. 1995. * Y NotOtice: Subjubject to anyy disclaimer,disclai theh term off thisthi Y. Usuda, et al., Journal of Bacteriology, vol. 179, No. 22, patent is extended or adjusted under 35 pp. 6959 to 6964, “Molecular Cloning and Transcriptional U.S.C. 154(b) by 0 days. Analysis of a Guanosine Kinase Gene of Brevibacterium (21) Appl. No.: 08/913,816 Acetylicum ATCC 953”, Nov. 1997. Y. USuda, et al., Biochimica et Biophysica Acta 1341, pp. (22) PCT Filed: Mar. 22, 1996 200 to 206, "Characterization of Guanosine Kinase from (86) PCT No.: PCT/JP96/00761 Brevibacterium Acetylicum ATCC 953", 1997. H. Shirae, et al., BioSciences Information Service, 1 page, S371 (c)(1), XP-002147617, “Purification and Properties of Purine (2), (4) Date: May 13, 1998 Nucleoside Phosphorylase from Brevibacterium-Acetyli (87) PCT Pub. No.: WO96/30501 cum ATCC 954, 1991.
    [Show full text]
  • Original Article Effect of Nucleoside and Nucleotide Reverse Transcriptase Inhibitors of HIV on Endogenous Nucleotide Pools
    Antiviral Therapy 13:789–797 Original article Effect of nucleoside and nucleotide reverse transcriptase inhibitors of HIV on endogenous nucleotide pools Jennifer E Vela1, Michael D Miller2, Gerald R Rhodes1 and Adrian S Ray1* 1Department of Preclinical Drug Metabolism, Gilead Sciences, Inc., Foster City, CA, USA 2Department of Clinical Virology, Gilead Sciences, Inc., Foster City, CA, USA *Corresponding author: E-mail: [email protected] Background: Alterations in endogenous nucleotide pools Incubation of 10 µM AZT, either alone or in combination as a result of HIV therapy with nucleoside and nucleotide with other N(t)RTIs, increased 2′-deoxyadenosine triphos- reverse transcriptase inhibitors (N[t]RTIs) is a proposed phate, 2′-deoxyguanosine triphosphate and thymidine mechanism for therapy-related adverse events and drug triphosphate levels by up to 1.44-fold the concentrations interactions resulting in treatment failure. In vitro stud- observed in untreated cells. At higher than pharmaco- ies were performed in order to understand the effect of logical concentrations of AZT, evidence for inhibition of N(t)RTIs on endogenous nucleotide pools. 2′-deoxycytidylate deaminase and enzymes involved in the Methods: The T-cell line CEM-CCRF was treated with control salvage of thymidine was also observed. Phosphorylated antimetabolites or the N(t)RTIs abacavir, didanosine, lami- metabolites of TFV are known to inhibit purine nucleoside vudine, tenofovir (TFV) and zidovudine (AZT), either alone phosphorylase (PNP). However, in contrast to a potent PNP or in combination. The levels of natural 2′-deoxynucleoside inhibitor, TFV was unable to alter intracellular dNTP pools triphosphates (dNTP) and ribonucleoside triphophosphates upon addition of exogenous 2′-deoxyguanosine.
    [Show full text]
  • Chimp Report
    ChImp Report Chances and Implications of an Expanded Genetic Code iGEM Bielefeld-CeBiTec 2017 Table of Contents Abstract ...................................................................................................................................... 3 Motivation .................................................................................................................................. 4 Background ................................................................................................................................ 6 Historical Background ............................................................................................................ 6 Legal Situation in Germany ................................................................................................... 8 Current State of Research of expanded or synthetic DNA ..................................................... 9 Chances and Implications of an Expanded Genetic Code ........................................................ 12 The Scientific Perspective .................................................................................................... 12 The Philosophical and Ethical Perspective .......................................................................... 16 The Religious Perspective .................................................................................................... 21 The Public´s Perspective ...................................................................................................... 26 Results .....................................................................................................................................
    [Show full text]
  • Different Modes of Transport for 3H-Thymidine, 3H-FLT, and 3H-FMAU in Proliferating and Nonproliferating Human Tumor Cells
    Different Modes of Transport for 3H-Thymidine, 3H-FLT, and 3H-FMAU in Proliferating and Nonproliferating Human Tumor Cells David A. Plotnik1, Lindsay E. Emerick1, Kenneth A. Krohn2, Jashvant D. Unadkat3, and Jeffrey L. Schwartz1 1Department of Radiation Oncology, University of Washington, Seattle, Washington; 2Department of Radiology, University of Washington, Seattle, Washington; and 3Department of Pharmaceutics, University of Washington, Seattle, Washington The basis for the use of nucleoside tracers in PET is that activity of the cell-growth–dependent enzyme thymidine kinase 1 is the PET provides a noninvasive approach to measuring tumor rate-limiting factor driving tracer retention in tumors. Recent growth and response to therapy (1,2). Labeled thymidine and publications suggest that nucleoside transporters might influ- 3 9 9 ence uptake and thereby affect the tracer signal in vivo. Under- thymidine analogs such as [methyl- H]-3 -deoxy-3 -fluoro- 3 3 standing transport mechanisms for different nucleoside PET thymidine ( H-FLT) and H-1-(2-deoxy-2-fluoro-b-D-arabi- tracers is important for evaluating clinical results. This study nofuranosyl)-5-methyluracil (3H-FMAU) are being studied examined the relative role of different nucleoside transport for their use as PET-based proliferation tracers (3–7). The mechanisms in uptake and retention of [methyl-3H]-39-deoxy- primary factor driving nucleoside uptake and retention in 9 3 3 3 3 -fluorothymidine ( H-FLT), [methyl- H]-thymidine ( H-thymi- tumors is assumed to be thymidine kinase 1 (TK1) (a cyto- dine), and 3H-1-(2-deoxy-2-fluoro-b-D-arabinofuranosyl)-5- methyluracil (3H-FMAU). Methods: Transport of 3H-FLT, 3H- solic enzyme).
    [Show full text]
  • Mass Spectrometry – a Powerful Tool for Metabolomics Sandy Nargund Manager, MS & Chromato Shimadzu [Asia-Pacific] Pte Ltd
    Mass Spectrometry – A Powerful tool for metabolomics Sandy Nargund Manager, MS & Chromato Shimadzu [Asia-Pacific] Pte Ltd 1 2 Biomarkers Identification and Validation 3 Mass Spectrometry –For Metabolomics GCMS-QP2010 Ultra GCMS-TQ 8040 LCMS-8060 Nexera UC- Online SFE/SFC iDPlus-Performance Bacterial Identification MALDI -7090 High Resolution TOF iMScope-Trio –Mass imaging 4 t Triple Quadrupole MS/MS Product ion scan t MRM- Multi Reaction Monitoring SIM (single analysis) MRM (MS/MS analysis) 50000 10 ppb 7500 10 ppb 40000 5000 30000 20000 2500 10000 0 0 1.0 1.5 2.0 2.5 min 1.0 1.5 2.0 2.5 min Eliminates background for High sensitivity but high trace-level quantitation with background high S/N GCMS- Gold Standard for Metabolomics 7 Metabolomics Research Using GC-MS/MS Metabolomics Research Discovery phase Validation phase Scan measurement MRM measurement MRM measurement (GC-MS/MS) (non-targeted analysis) (wide target analysis) (target analysis) Detect marker candidates Quantitate marker candidates and identify compounds with higher accuracy Accurate quantitation GC/MS Metabolite Database Ready to use method for quick start your Research 1. Method files Registered Measurement Number Derivatives Compounds Mode Registered 2. Library (scan) Organic acids, fatty Scan 428 3. Smart MRM database acids, amino acids, TMS sugars, etc. MRM 193 (automatic method creation tool) Scan 50 4. Instruction manuals Fatty acids Methylation MRM 50 Amino acids EZ:faastTM Scan 33 Easy Work Flow AART function for Automatic Adjustment of Retention Indices with just one injection Select components for measurement from the database. Smart MRM database Method is created Automatically Start acquisition.
    [Show full text]
  • Hypoxanthine-Guanine Phosphoribosyltransferase Deficiency: Activity in Normal, Mutant, and Heterozygote- Cultured Human Skin Fibroblasts Wilfred Y
    Proceedings of the National Academy of Sciences Vol. 65, No. 3, pp. 577-584, March 1970 Hypoxanthine-Guanine Phosphoribosyltransferase Deficiency: Activity in Normal, Mutant, and Heterozygote- Cultured Human Skin Fibroblasts Wilfred Y. Fujimoto* and J. Edwin Seegmillert SECTION ON HUMAN BIOCHEMICAL GENETICS, NATIONAL INSTITUTE OF ARTHRITIS AND METABOLIC DISEASES, NATIONAL INSTITUTES OF HEALTH, BETHESDA, MARYLAND Communicated by E. R. Stadtman, June 27, 1969 Abstract. Cultured skin fibroblasts from patients deficient for the enzyme hypoxanthine-guanine phosphoribosyltransferase (PRT) activity show very low but nevertheless significant levels of apparent PRT enzyme despite absence of detectable activity (<0.004% of normal) in erythrocytes of the same patients. In fibroblasts this mutant enzyme is more heat labile than the normal enzyme. These findings indicate that PRT deficiency in this disorder is not due to a dele- tion mutation of the PRT locus. Individual cultured skin fibroblasts from heterozygote females for PRT defi- ciency show normal, intermediate, or very low levels of PRT activity. The mosaicism demonstrated in the heterozygotes for this X-linked disorder ac- counts for the cells with normal and very low activities of PRT. Intermediate activity can best be explained by the phenomenon of metabolic cooperation pre- sumably from the transfer of either PRT enzyme or messenger RNA, from nor- mal to mutant cells. The enzyme hypoxanthine-guanine phosphoribosyltransferase (PRT) (E.C. 2.4.2.8.) is not detectable, (<0.004% of normal activity), in erythrocyte hemoly- sates from patients affected with the Lesch-Nyhan syndrome, an X-linked reces- sive familial disorder characterized by spasticity, choreoathetosis, psychomotor retardation, a compulsive automutilation by biting of the lips and fingers, and accelerated purine synthesis de novo.1.
    [Show full text]